Vanta Bioscience Limited reported earnings results for the full year ended March 31, 2022. For the full year, the company reported sales was INR 96.88 million compared to INR 100.38 million a year ago. Revenue was INR 101.11 million compared to INR 100.73 million a year ago. Net income was INR 0.882 million compared to INR 4.5 million a year ago. Basic earnings per share from continuing operations was INR 0.14 compared to INR 0.71 a year ago. Diluted earnings per share from continuing operations was INR 0.14 compared to INR 0.71 a year ago.